Mayne Pharma Snapshot
Mayne Pharma is banking that it will become the main source of injectable generic drugs and oncology treatments. Focused primarily on the development, manufacturing, and sale of drugs used by oncologists, the company's core expertise is in making generic chemotherapy medications in the taxanes and platinum derivatives families, but it has also branched out and started to produce other kinds of drugs used in cancer treatments, including antibiotics and painkillers. Mayne Pharma distributes its products in more than 65 countries, with strong positions in Australia, North America, and Western Europe. The company is a subsidiary of Hospira.
